Alexandre Passioukov MD, PhD

Alexandre Passioukov leads translational medicine efforts across oncology, CNS and dermatology therapeutic areas at Pierre-Fabre R&D involving a few CDx at the different developmental stage. Previously, Dr. Passioukov was leading translational medicine programs at Roche (Switzerland) with a special focus on precision medicine approaches for immune-oncology drugs. Prior to joining Roche, Alexandre served as Head of Translational Research at EORTC in Brussels, conducting structural translational medicine activities of European clinical research networks. Alexandre is MD with PhD in biology by Université Catholique de Louvain (UCL), where he was closely involved in the launch of 2 spin-off biotech companies: Coulter Pharma Belgium and Diatos.